Guyasuta Investment Advisors’s AstraZeneca AZN Stock Holding History

Guyasuta Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,953	Closed	-$259K	–	251
2022 Q1	$259K	Hold	1,953	–	–	0.02%	241
2021 Q4	$227K	Hold	1,953	–	–	0.01%	261
2021 Q3	$235K	Buy	1,953 +230	+13%	+$26.8K	0.02%	247
2021 Q2	$206K	Buy	+1,723	New	+$189K	0.01%	259
2016 Q1	–	Sell	-10,163	Closed	-$690K	–	207
2015 Q4	$690K	Sell	10,163 -1,610	-14%	-$106K	0.1%	115
2015 Q3	$749K	Buy	+11,773	New	+$775K	0.11%	114

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Guyasuta Investment Advisors's AZN Position: Q2 2022 in Review

Guyasuta Investment Advisors sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 1,953 shares — an estimated $259K sold.

Guyasuta Investment Advisors first reported a position in AZN in Q3 2015 and held it in 6 quarters. The position peaked at $749K in Q3 2015. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

Guyasuta Investment Advisors reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
Guyasuta Investment Advisors sold 1,953 AstraZeneca shares in Q2 2022, an estimated $259K.
Guyasuta Investment Advisors first reported a position in AstraZeneca in Q3 2015 and held it in 6 quarters.
Guyasuta Investment Advisors's AstraZeneca position peaked at $749K in Q3 2015.
1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2022, filed 21 Jul 2022.